Sernova Biotherapeutics
(OTC) SEOVF
Sernova Biotherapeutics Financials at a Glance
Market Cap
$38.67M
Revenue (TTM)
$0.00
Net Income (TTM)
$12.39M
EPS (TTM)
$-0.03
P/E Ratio
-4.27
Dividend
$0.00
Beta (Volatility)
0.41 (Low)
Dividend
$0.00
Beta (Volatility)
0.41 (Low)
Price
$0.11
Volume
26,500
Open
$0.11
Price
$0.11
Volume
26,500
Open
$0.11
Previous Close
$0.11
Daily Range
$0.11 - $0.11
52-Week Range
$0.09 - $0.17
Dividend
$0.00
Beta (Volatility)
0.41 (Low)
Price
$0.11
Volume
26,500
Open
$0.11
Previous Close
$0.11
Daily Range
$0.11 - $0.11
52-Week Range
$0.09 - $0.17
SEOVF News
SEOVF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sernova Biotherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Jonathan M. N. Rigby, MBA
Website
www.sernova.comHeadquarters
London, ON N6G 4X8, GB
SEOVF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
50%
Return on Assets
-12%
Earnings Yield
-23.42%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$38.67M
Shares Outstanding
336.70M
Volume
26.50K
Short Interest
0.00%
Avg. Volume
52.50K
Financials (TTM)
Gross Profit
$342.54K
Operating Income
$15.02M
EBITDA
$14.66M
Operating Cash Flow
$10.91M
Capital Expenditure
$0.00
Free Cash Flow
$10.91M
Cash & ST Invst.
$264.97K
Total Debt
$17.28M
Sernova Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$4.44K
N/A
Gross Margin
0.00%
N/A
Market Cap
$38.67M
N/A
Market Cap/Employee
$2.27M
N/A
Employees
17
N/A
Net Income
$2.34M
+58.9%
EBITDA
$2.11M
+60.9%
Quarterly Fundamentals
Net Cash
$17.00M
-2671.5%
Accounts Receivable
$125.78K
-66.3%
Inventory
$0.00
N/A
Long Term Debt
$1.08M
+145.6%
Short Term Debt
$16.50M
+15431.9%
Return on Assets
-12.23%
N/A
Return on Invested Capital
50.18%
N/A
Free Cash Flow
$1.05M
+78.3%
Operating Cash Flow
$1.05M
+78.3%